Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23% year-over-year to
Infographic: How Tilray (TLRY) performed in Q3 2022
Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23% year-over-year to
[caption id="attachment_135351" align="alignnone" width="1280"] Image: iStock[/caption] Can you briefly talk about your business model and the value you add to the market?
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q2 2022 earnings call dated Mar. 31, 2022 Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor Relations
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second quarter 2022 earnings results today. Sales increased 3% year-over-year to $33.8 billion. Sales growth
Sigma Healthcare Ltd ( ?????? : SIG) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Vikesh Ramsunder -- Chief Executive Officer and
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive Officer
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company's revenues
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities into overdrive,
Neogen Corporation (NASDAQ: NEOG) Q3 2022 earnings call dated Mar. 24, 2022 Corporate Participants: John Adent -- Chief Executive Officer and President Steve Quinlan -- Chief
Cresco Labs Inc. (NASDAQ: CL) Q4 2021 earnings call dated Mar. 23, 2022 Corporate Participants: Jake Graves -- Investor Relations Charles Bachtell -- Chief Executive Officer
HealthEquity, Inc (NASDAQ: HQY) Q4 2022 earnings call dated Mar. 22, 2022 Corporate Participants: Richard Putnam -- Vice President of Investor Relations Jon Kessler -- President
CareRx Corporation (TSX: CRRX) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: David Murphy -- President and Chief Executive Officer Andrew Mok -- Chief
Cipher Pharmaceuticals, Inc. ( TSX: CPH) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been busy enhancing its capabilities in healthcare delivery lately, through various initiatives including M&A deals.
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q4 2021 earnings call dated Mar. 15, 2022 Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and Chief
After starting the year on a high note, the IPO market is currently going through a slow phase mainly due to the
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q4 2021 earnings call dated Mar. 11, 2022 Corporate Participants: Will O'Connor -- Investor Relations Peter Nielsen -- President, Chief Executive
Essilorluxottica (PA: EL) Q4 2021 earnings call dated Mar. 11, 2022 Corporate Participants: Giorgio Iannella -- Head of Investor Relations Francesco Milleri -- Chief Executive Officer
Avid Bioservices, Inc. (NASDAQ: CDMO) Q3 2022 earnings call dated Mar. 08, 2022 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President & Chief
Patterson Companies, Inc. (NASDAQ: PDCO) Q3 2022 earnings call dated Mar. 02, 2022 Corporate Participants: John M. Wright -- Vice President, Investor Relations Mark
PetIQ, Inc. (NASDAQ: PETQ) Q4 2021 earnings call dated Mar. 01, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer And